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Abstract
Hemodynamic stability is one of the most critical aspects of adrenal surgery for pheochromocytoma. Few articles have evaluated the
hemodynamic status of patients undergoing posterior retroperitoneal adrenalectomy (PRA) for pheochromocytoma. The aim of this
study is to compare the intraoperative hemodynamic parameters between lateral transperitoneal adrenalectomy (TPA) and PRA in
this groups of patients.
This report describes a retrospective study of 53 pheochromocytoma patients who underwent endoscopic adrenalectomy via
transperitoneal (22 patients) or posterior retroperitoneal (31 patients) approaches from January 2008 toMarch 2015. Data from these
patients were compared to investigate the differences in hemodynamic parameters between the 2 approaches.
Clinical parameters at presentation were similar between the 2 groups, except for tumor size, which was larger in the TPA group.
The PRA group is associated with reduced operative time, blood loss, and length of hospital stay compared to TPA even after
adjusting for the tumor size. There was greater BP fluctuations and higher maximum systolic and diastolic blood pressure (BP) within
the TPA group compared to PRA during univariate analysis. This was however not significant after adjusting for tumor size. There was
no difference in the intraoperative inotropic support requirement between the 2 groups.
PRA is associated with stable intraoperative hemodynamic status, as well as favorable perioperative outcomes compared to TPA
in patients with small pheochromocytomas.
Abbreviations: BP = blood pressure, EBL = estimated blood loss, IVC = inferior vena cava, LA = laparoscopic adrenalectomy,
LOS = length of stay, PRA = posterior retroperitoneal adrenalectomy, TPA = transperitoneal adrenalectomy.
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11. Introduction
Pheochromocytoma is often regarded as a confounding tumor
because of physiological issues and technical challenges encoun-
tered before, and during surgery. Since the 1990s, laparoscopic
adrenalectomy (LA) has become the “gold standard” for the
treatment of small- to moderate-sized adrenal tumors. Multiple
studies have demonstrated the safety and efficacy of LA for the
management of pheochromocytoma compared with open
adrenalectomy.[1–3] Among the various approaches of LA, lateral
transperitoneal adrenalectomy (TPA) was traditionally preferred
by surgeons due to increased familiarity with the anatomy and
operating view. Nevertheless, posterior retroperitoneoscopic
adrenalectomy (PRA) has been gaining popularity with several
benefits over traditional approaches. PRA can provide direct and
rapid access to the adrenal gland without mobilizing intraperito-
neal organs or lysing adhesions from prior abdominal operations,
as well as the ability to perform bilateral adrenalectomy without
repositioning the patient.[4–10] However, there is still a paucity of
data regarding the intraoperative hemodynamic status of PRA in
pheochromocytoma patients. The author recently started con-
ducting PRA, as described by Dr. Walz, for various adrenal
pathologies including pheochromocytoma. PRA is the preferred
approach in our institution in most cases, and we have reported
excellent surgical outcomes.[4–10] The aim of this study is to
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the TPA and PRA approaches, specifically focusing on the
intraoperative hemodynamic changes.2. Materials and methods
2.1. Patients
The study included a total of 362 consecutive patients who
underwent LA from January 2008 to March 2015 for various
adrenal pathologies in the Department of Endocrine Surgery,
Yonsei University College of Medicine, Seoul, Korea. Among
these, 14 (19.7%) and 57 (80.3%) patients with pheochromocy-
toma underwent open and endoscopic adrenalectomies, respec-
tively. The records of 57 patients who underwent endoscopic
adrenalectomy due to pheochromocytoma were retrospectively
reviewed. Four cases of bilateral adrenalectomies and combined
cases were excluded, leaving a total of 53 patients enrolled in this
study. The surgical outcomes and intraoperative hemodynamic
parameters of both patient groups were compared. All patients
exhibited preoperative hypertension (systolic blood pressure (BP)
>140 mm Hg; diastolic BP > 100 mm Hg) and were thus
prepared for surgery by administration of an alpha-blocker
(phenoxybenzamine) for 2 weeks to control their BP and block
catecholamine surges during the operation. Additionally, patients
exhibiting tachycardia were treated with beta-blockers. To
prevent postoperative hypotension, adequate hydration was
applied to all patients preoperatively. Pheochromocytoma
diagnosis was based on preoperative manifestation of excess
catecholamine and postoperative pathologic confirmation.
Central venous and arterial catheters were used for all patients.
This study was approved by the Institutional Review Board of
Yonsei University College of Medicine (IRB 4-2018–0578).
Individual patient consent was waived because of the retrospec-
tive nature of the study.Table 1
Clinicopathological characteristics of transperitoneal adrenalect-
omy vs posterior retroperitoneal adrenalectomy.
TPA (N=22) PRA (N=31) P value
Mean age, year 47.32±14.17 48.74±13.90 .717
Gender [female: male] 13: 9 16: 15 .59
Mean BMI, kg/m2 23.92±4.74 22.64±2.50 .2063. Methods of operation
3.1. TPA
With the patient positioned in a lateral decubitus position, the
operative bed was flexed just above the level of the iliac crest, and
the lumbar bridge was elevated to maximally widen the space
between the iliac crest and the costal margin. We generally used 3
ports for left adrenalectomies and 4 trocars for the right side. All
trocars were inserted 2cm caudally from the subcostal margin to
ensure adequate space between instruments. For left sided
operations, the spleen and pancreatic tail were mobilized and
retracted anteromedially to expose the left adrenal gland. For the
right side, the right lobe of the liver was mobilized and retracted
medially to expose the adrenal gland and inferior vena cava
(IVC). Once exposed, the adrenal gland was detached from the
kidney and retroperitoneal soft tissue. All feeding vessels were
ligated using a Harmonic Scalpel (Ethicon Endo-Surgery,
Cincinnati, OH), and the central vein of the adrenal gland was
clipped and divided.Preoperative SBP, mm Hg 137.33±19.28 133.21±23.26 .545
Tumor side, n (%) <.001
Right 5 (22.7) 23 (74.2)
Left 17 (77.3) 8 (25.8)
Mean tumor size, cm 6.24±2.84 3.77±1.64 <.001
BMI = body mass index, PRA = posterior retroperitoneal adrenalectomy, SBP = systolic blood
pressure, TPA = transperitoneal adrenalectomy.3.2. PRA
The patient is placed in the prone jackknife position with the hip
joint at right angle to maximize exposure of the posterior
retroperitoneal space from the subcostal margin to the iliac crest.
A 1.5cm transverse skin incision is made just below the lowest tip2of the 12th rib. A 10-mm trocar is then inserted through a second
incision located 2 to 3cm medially from the first incision. A third
skin incision for another 5-mm trocar is made along the lowest
margin of the 11th rib approximately 4 to 5cm laterally from the
first incision. A 12-mm blunt trocar with a ballooning tip is
inserted through the first incision, and CO2 is insufflated up to 18
mm Hg pressure for pneumoretroperitoneum creation. After
creating the retroperitoneal working space, renal hilar dissection
and mobilization of the kidney upper pole are initially performed
to expose the lowest part of the adrenal tumor. We start the
tumor dissection with lower margin detachment from the upper
pole of kidney in a medial to lateral direction. After isolation and
ligation of the adrenal central vein, the adrenal gland is
circumferentially dissected away from the surrounding adipose
tissue.3.3. Statistical analysis
Comparison between TPA and PRAwasmade by applying Fisher
exact test for the categorical variables and Student t test for the
continuous variables. Variables that did not meet the normality
assumption were log-transformed and noted accordingly in the
tables. The linear regression model was used to analyze the
relationship between each parameter and surgical approaches,
with and without the confounding factor being adjusted. The
significance level was set as a = 0.05. All analysis was carried out
using R version 3.2.2 (The R Foundation for Statistical
Computing, Vienna, Austria).4. Results
The patients clinicopathologic characteristics are summarized in
Table 1. The mean tumor size was 4.80±2.51cm. There was no
need for blood transfusion or conversion to laparotomy, and no
mortalities or serious complications were observed in either
group.
TPA was performed in 22 patients (41.5%) and PRA in 31
patients (58.5%), respectively. There were no significant differ-
ences in patient age, gender, body mass index, and preoperative
systolic BP between those 2 groups. There was however a
significant difference in the tumor size (TPA: 6.24±2.84 vs PRA:
3.77±1.64cm, P< .001) (Table 1).
The surgical outcomes for patients who underwent TPA vs
PRA are shown in Table 2. The PRA group demonstrated a
shorter mean operative time (TPA: 145.23±64.63 vs PRA: 80.90
±26.28minutes, P< .001) and lower estimated blood loss (EBL)
Table 2
Operative outcomes of transperitoneal adrenalectomy vs poster-
ior retroperitoneal adrenalectomy.
TPA (N=22) PRA (N=31) P value
Mean operation time, min 145.23±64.63 80.90±26.28 <.001
Estimated blood loss 271.82±351.20 35.81±53.59 .001
Conversion to open, n (%) 0 0
ICU stay, n (%) 7 (31.8) 2 (6.5) .025
Complication 0 1
(pleural effusion) > .99
Intervals from operation to
first oral diet, day
1.40±0.91 .34±0.48 <.001
Mean hospital stay, days 5.82±2.81 3.29±1.47 <.001
ICU = intensive care unit, PRA = posterior retroperitoneal adrenalectomy, TPA = transperitoneal
adrenalectomy.
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ml, P= .001). The PRA group also had less ICU stay (TPA: 7 cases
vs PRA: 2 cases, P= .025) and interval to first oral intake after
operation (TPA: 1.40±0.91 vs PRA: 0.34±0.48 days, P< .001).
Additionally, the mean postoperative length of hospital stay
(LOS) was shorter in the PRA group (TPA: 5.82±2.81 vs PRA:
3.29±1.47 days, P< .001). Pleural effusion occurred in 1 patient
in the PRA group but resolved with conservative management
in a week.
The intraoperative hemodynamic parameters of these 2 groups
are described in Table 3. There were no significant differences
between the groups in the incidence of extreme hypertensive
episodes (systolic BP≥200 mm Hg), extreme hypotensive
episodes (systolic BP80 mm Hg) and the highest and lowest
heart rates. However, significant differences were observed in the
mean highest intraoperative systolic BP (TPA: 177.73±23.08 vs
PRA: 156.39±26.93 mm Hg, P= .004) and diastolic BP (TPA:
102.36±22.46 vs PRA: 88.19±12.37 mm Hg, P= .005). The
differences between the highest and lowest systolic and diastolic
BP, which reflect intraoperative BP fluctuation, was significantly
wider in the TPA group than that in the PRA group (maximal
difference of systolic BP [TPA: 88.14±23.93 vs PRA vs 66.03±
27.63 mmHg, P= .004], maximal difference of diastolic BP [TPATable 3
Intraoperative hemodynamic parameters of transperitoneal adrenale
T
Highest intraoperative BP, mm Hg
Mean systolic BP 17
Mean diastolic BP 10
Lowest intraoperative BP, mm Hg
Mean systolic BP 8
Mean diastolic BP 5
Incidence of systolic BP ≥ 200 mm Hg, n (%)
Incidence of systolic BP < 80 mm Hg, n (%)
Mean highest heart rate, beat/min 10
Mean lowest heart rate, beat/min 6
Incidence of highest HR ≥ 110 bpm, n (%)
Incidence of lowest HR < 50 bpm, n (%)
Highest systolic BP – lowest systolic BP, mmHg 8
Highest diastolic BP – lowest diastolic BP, mmHg 5
Patients requiring intraoperative vasodilator drugs, n (%)
Patients requiring intraoperative vasoconstrictive drugs, n (%)
BP = blood pressure, HR = heart rate, PRA = posterior retroperitoneal adrenalectomy, TPA = transpe
3vs PRA 51.36±23.02 vs 36.35±14.18, P= .005], respectively).
There was no significant difference in the intraoperative use of
vasoconstrictive or vasodilatory drugs between the 2 groups.
To evaluate the detailed relationship between each significant
parameter and the 2 different surgical approaches, the linear
regression model was used, with and without confounding factor
being adjusted (Table 4). All parameters in the unadjusted model
showed significant differences between the 2 groups. The beta
indicates the different mean values in the parameters between the
2 groups (TPA vs PRA). For example, the beta in the operation
time is 64.32, which indicates that the mean operating time in
PRA was 64.3 minutes less than that in TPA; this difference was
statistically significant (P< .001). To overcome the bias that can
be caused by different tumor sizes between the 2 groups, the
linear regression model was adjusted by the tumor size as the
confounding factor, and the size-adjusted model was used. In the
adjusted model, the average operation time, EBL, and LOS were
significantly less in the PRA group than in the TPA group. Other
parameters, which reflect the hemodynamic stability during the
operation, showed a decreasing trend in the PRA group;
however, they were not significantly different.5. Discussion
Pheochromocytoma is a rare tumor arising from chromaffin cells
of the adrenal medulla. Since Charles Mayo and Cesar Roux first
reported the successful surgical removal of pheochromocytoma
in 1926,[11] the progress in understanding the pathophysiology of
pheochromocytoma, improvement in medical and anesthetic
care, and advances in surgical techniques have resulted in
excellent outcomes for patients with these tumors. Since the
introduction of LA in the early 1990s,[12] several groups have
demonstrated that LA affords multiple advantages over conven-
tional open adrenalectomy.[13,14] Furthermore, LA has been
demonstrated to be a feasible treatment option for patients with
pheochromocytoma.[1–3,15–18]
TPA and PRA are the most commonly performed techniques
for conducting LA. Currently, most surgeons prefer TPA because
of the large working space, great visibility, increased familiarity
with the anatomy, and the ability to conduct another operationctomy vs posterior retroperitoneal adrenalectomy.
PA (N=22) PRA (N=31) P value
7.73±23.08 156.39±26.93 .004
2.36±22.46 88.19±12.37 .005
8.59±6.76 90.35±12.09 .79
1.00±6.25 51.84±7.81 .68
5 (22.7%) 2 (6.5%) .11
1 (4.5%) 5 (16.1%) .38
3.95±19.17 94.32±19.04 .08
8.77±11.78 63.45±10.36 .09
9 (40.9%) 6 (19.4%) .12
1 (4.5%) 3 (9.7%) .63
8.14±23.93 66.03±27.63 .004
1.36±23.02 36.35±14.18 .005
13 (59.1%) 15 (48.4%) .44
7 (31.8%) 12 (58.5%) .61
ritoneal adrenalectomy.
Table 4
Linear regression model according to outcome comparing transperitoneal adrenalectomy and posterior retroperitoneal adrenalectomy;
Adjusted by tumor size.
Variable Unadjusted Adjusted
Beta SE P value Beta SE P value
Mean operation time, mins –64.324 12.854 <.0001 –47.722 14.065 .001
Mean estimated blood loss, mls –236.012 63.860 .0005 –166.678 71.065 .02
Mean hospital stay, days –2.528 0.592 .0001 –2.295 0.681 .001
Highest intraoperative BP (systolic) mm Hg –21.340 7.085 .0040 –9.226 7.402 .22
Highest intraoperative BP (diastolic) mm Hg –14.170 4.810 .0048 –5.950 5.026 .24
Highest systolic BP – lowest systolic BP, mm Hg –22.104 7.295 .0038 –10.151 7.691 .19
Highest diastolic BP – lowest diastolic BP, mm Hg –15.009 5.113 .0050 –7.159 5.457 .20
BP = blood pressure, PRA = posterior retroperitoneal adrenalectomy, SE = standard error, TPA = Reference for beta value, TPA = transperitoneal adrenalectomy.
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intraperitoneal space, injury or irritation of intraperitoneal
organs can sometimes occur, which is the most common cause of
postoperative ileus.[19]
Recently, PRA has been demonstrated to be a safe and effective
procedure for various adrenal lesions with excellent surgical
outcomes. PRA permits direct access to the adrenal gland,
without any intraperitoneal visceral contact. In addition, PRA
does not require adhesiolysis in patients with previous abdominal
operations to expose the adrenal gland. Multiple reports have
demonstrated the advantages of PRA in terms of early
postoperative mobilization, reduced LOS, minimal blood loss,
and reduced postoperative pain. In addition, this approach offers
the option of bilateral adrenalectomy without repositioning the
patient, which markedly reduces operation time.[9,10,20,21]
To our knowledge, there has only been 1 published article
comparing the intraoperative hemodynamic status in patients
undergoing PRA and TPA for pheochromocytoma.[22] The article
by Vorselaars et al was a multi-institutional retrospective analysis
of 341 patients across 6 medical centers in Europe, the United
States, and Canada. It reviewed the hemodynamic instability
during adrenalectomy using the transperitoneal vs retroperito-
neal approaches for pheochromocytoma. The authors concluded
that the retroperitoneal approach carries a greater risk of
significant hypotension during surgery. However, the overall
cardiovascular morbidity rates were similar between the 2
groups, and the occurrence of hemodynamic instability was
influenced by the medical center where the operations were
performed, which is one of the limitations of the study. Our study
in contrast, is a single institution study, whereby all the surgeries
were performed by a single surgeon, thus eliminating the different
operating techniques and preoperative preparation and intraop-
erative patient management as confounding factors. Based on our
results, PRA for pheochromocytoma provided favorable intra-
operative hemodynamic stability compared with TPA. In our
study, the number of extreme hypertensive or hypotensive
episodes were similar between the 2 groups; however, the mean
maximal systolic and diastolic BP was significantly higher in TPA
during the operation. Furthermore, the difference between
maximal and minimal systolic and diastolic BP were significantly
greater with TPA than that for PRA, suggesting that BP
fluctuation during PRA was more controllable than TPA.
Several reports have highlighted the importance of early
ligation of the adrenal central vein in pheochromocytoma
patients. This reduces the risk of excessive catecholamine
secretion,[23–25] thus preventing fluctuation of intraoperative
BP in these patients. In PRA, direct handling of the tumor before4ligation of central vein is not frequent; therefore, the risk of
catecholamine surge is relatively low.
In left sided PRA, the first step is exposing the renal hilum
without touching the tumor. The central veinwhich drains directly
into the renal vein can then be exposed and clipped relatively
quickly before the tumor is dissected. On the right side, the vein is
reached in an early phase of the procedure. After dissecting the
renal hilum, the inferior adrenal vessels andmiddle adrenal arteries
are exposed just above the IVC and ligated. Further dissection of
the posterior aspect of IVC and the inferior margin of the adrenal
gland facilitates exposure of the central vein, which can be ligated
without significant handling of the tumor. Thus, the anatomical
benefits in PRA enables minimum manipulation of the tumor and
early identification and ligation of the central vein.
The significant reduction in blood loss observed in patients
undergoing PRA is possibly due to the relatively less dissection
required to expose the adrenal gland. In addition, high gas
insufflation pressure of more than 18 mm Hg during PRA (as
opposed to 12–15 mm Hg of pneumoperitoneum during TPA)
tends to induce tamponade of minor bleeding from small vessels.
Furthermore, in PRA, venous returns from the adrenal gland are
usually reduced as the IVC or renal vein are compressed by the
high retroperitoneal insufflation pressure; thereby, decreasing the
risk of hemodynamic instability by reducing catecholamine
release during the procedure.
A review of the literature concerning the size limits of tumors
suitable for PRA suggests that tumors between 5 to 7cm as good
candidates for PRA.[10,26–28] Walz, et al additionally suggested
that hormonally active 7cm tumors could be safely resected using
PRA.[29] This method utilizes a smaller working space and closer
laparoscopic ports than TPA, which can lead to manipulation
problems when tumors are large.[9] Based on these studies, the
authors excluded patients with tumors >8cm in size, clear signs
of malignancy, a concomitant intra-abdominal pathology, or
severe obesity for PRA.[27]
The major limitation of this study was the small sample size
and non-controlled retrospective nature of the study. Specifically,
the mean tumor size in PRA was smaller than that in TPA. The
single surgeon who performed the operations only performed
TPA prior to 2009. From 2009 onwards, the surgeon started
using both techniques, and assigned the patients to either TPA or
PRA based on tumor size. Tumors greater than 6cm were
generally removed using the TPA method early on, but the size
criteria gradually increased to up to 8cm in recent years. Despite
including cases performed during the learning curve period,
outcomes between the 2 techniques were still comparable, if not
more favorable in the PRA group.
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related to catecholamine surge and BP fluctuation during surgery.
Observations in this study show that the intraoperative
hemodynamics of PRA was comparable to TPA, particularly
for smaller sized pheochromocytomas, acknowledging that the
data was biased towards PRA given the smaller tumors in that
group. After adjusting for tumor size, however, the mean
operating time, EBL and LOS were still less in the PRA group
compared with the TPA group.
6. Conclusion
The PRA approach produces favorable intraoperative hemody-
namic outcome compared to TPA for smaller sized pheochro-
mocytomas. Future larger, randomized studies will be required to
confirm the hemodynamic superiority of PRA in patients with
larger pheochromocytomas.Author contributions
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